Issue link: http://catalog.e-digitaleditions.com/i/114936
ITEM 2. PROPERTIES. The following are our principal manufacturing locations as of December 31, 2012: Location Segment Square Feet Mahwah, New Jersey Kiel, Germany Suzhou, China Selzach, Switzerland Freiburg, Germany Malvern, Pennsylvania Carrigtwohill, Ireland Freiburg, Germany Limerick, Ireland Stetten, Germany Rennes, France Portage, Michigan Arroyo, Puerto Rico San Jose, California Lakeland, Florida Flower Mound, Texas Phoenix, Arizona Guayama, Puerto Rico Neuch��tel, Switzerland Cestas, France Mountain View, California Cestas, France West Valley, Utah Reconstructive Reconstructive Reconstructive, Neurotechnology and Spine Reconstructive Reconstructive Reconstructive Reconstructive Reconstructive, MedSurg Reconstructive Reconstructive Reconstructive MedSurg MedSurg MedSurg MedSurg MedSurg MedSurg MedSurg Neurotechnology and Spine Neurotechnology and Spine Neurotechnology and Spine Neurotechnology and Spine Neurotechnology and Spine 531,000 173,000 158,000 137,000 119,000 88,000 72,000 68,000 58,000 33,000 31,000 1,034,000 220,000 185,000 125,000 114,000 93,000 46,000 88,000 79,000 62,000 35,000 29,000 Owned/ Leased Owned Owned Owned Owned Owned Leased Owned Leased Owned Owned Leased Owned Leased Leased Leased Leased Leased Leased Owned Owned Owned Leased Leased In addition, we maintain corporate, administrative and sales offices and warehousing and distribution facilities in multiple countries. We believe that our properties are suitable and adequate for the manufacture and distribution of our products. ITEM 3. LEGAL PROCEEDINGS. We are involved in various proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor and intellectual property, and other matters that are more fully described in Note 6 to the Consolidated Financial Statements in Item 8 of this report; this information is incorporated herein by reference. ITEM 4. MINE SAFETY. Not applicable. 8 Dollar amounts in millions except per share amounts or as otherwise specified